|
Market Closed -
Nasdaq
21:00:00 06/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 0.0549 USD | -8.65% |
|
-91.71% | -99.25% |
| 12:37am | Karyopharm Therapeutics Inc.(NasdaqGS:KPTI) dropped from S&P TMI Index | CI |
| 11-03 | Karyopharm Therapeutics Inc.(NasdaqGS:KPTI) dropped from Russell Microcap Growth Benchmark Index | CI |
| Market Cap | 1.36M 1.22M 1.12M 1.02M 1.92M 128M 1.98M 13.47M 5.37M 68.37M 5.12M 5.01M 216M | P/E 2026 * |
-0.01x | P/E 2027 * | -0.03x |
|---|---|---|---|---|---|
| Enterprise Value | 1.36M 1.22M 1.12M 1.02M 1.92M 128M 1.98M 13.47M 5.37M 68.37M 5.12M 5.01M 216M | EV / Sales 2026 * |
0.01x | EV / Sales 2027 * | 0.01x |
| Free-Float |
95.35% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| KPTI | Delayed | |
CBOE
| KPTI | Real-time | |
|
Tradegate
| 25K0 | Real-time | |
|
Boerse Muenchen
| 25K0 | Real-time | |
|
Deutsche Boerse AG
| 25K0 | Delayed | |
|
Börse Stuttgart
| 25K0 | Delayed |
Last Transcript: Karyopharm Therapeutics Inc.
| 1 day | -8.65% | ||
| 1 week | -91.71% | ||
| Current month | -91.71% | ||
| 1 month | -91.55% | ||
| 3 months | -97.18% | ||
| 6 months | -99.39% | ||
| Current year | -99.25% |
| 1 week | 0.04 |  | 0.16 |
| 1 month | 0.04 | | 0.99 |
| Current year | 0.04 | | 10.99 |
| 1 year | 0.04 | | 10.99 |
| 3 years | 0.04 | | 29.25 |
| 5 years | 0.04 | | 220.95 |
| 10 years | 0.04 | | 444.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Paulson
CEO | Chief Executive Officer | 58 | 02/05/2021 |
Lori Macomber
DFI | Director of Finance/CFO | 55 | 02/01/2025 |
Amama Sadiq
CTO | Chief Tech/Sci/R&D Officer | - | 31/03/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Barry Greene
BRD | Director/Board Member | 63 | 31/12/2012 |
| Director/Board Member | 61 | 31/03/2013 | |
Garen Bohlin
BRD | Director/Board Member | 78 | 02/10/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 01/10/26 | Sell | Controller/Auditor | -378 | 0.0017% | ||
| 01/09/26 | Sell | Controller/Auditor | -19 | 0.0001% | ||
| 28/07/26 | Sell | Executive/Senior Manager | -189 | 0.0008% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -8.65% | -91.71% | -98.95% | -99.58% | 1.36M | |
| -0.79% | -4.48% | +44.44% | +127.49% | 1,216B | |
| +1.43% | +1.11% | +47.73% | +82.08% | 656B | |
| +1.07% | -1.21% | +32.99% | +106.31% | 509B | |
| -0.36% | -3.25% | +47.17% | +64.58% | 384B | |
| -0.14% | -1.87% | +71.05% | +40.63% | 362B | |
| -0.78% | -0.52% | +30.57% | +57.98% | 311B | |
| -0.80% | +6.73% | +11.89% | +35.64% | 293B | |
| +0.03% | -1.20% | +45.89% | +68.76% | 249B | |
| -0.41% | -2.22% | +35.24% | +105.68% | 208B | |
| Average | -1.08% | -8.78% | +26.80% | +58.96% | 418.78B | |
| Weighted average by Cap. | -0.23% | +0.03% | +42.43% | +88.36% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 136M 122M 111M 101M 191M 12.75B 197M 1.34B 534M 6.8B 509M 498M 21.48B | 174M 156M 142M 130M 245M 16.32B 252M 1.71B 684M 8.71B 651M 638M 27.48B |
| Net income | -160M -144M -131M -120M -226M -15.06B -233M -1.58B -631M -8.03B -601M -588M -25.36B | -115M -103M -94.18M -85.97M -162M -10.8B -167M -1.14B -453M -5.76B -431M -422M -18.19B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/11/26 | US$0.0549 | -8.65% | 90,110,455 |
| 05/11/26 | US$0.0601 | -17.56% | 18,847,981 |
| 04/11/26 | US$0.0729 | -17.44% | 40,915,198 |
| 03/11/26 | US$0.0883 | -21.16% | 16,868,112 |
| 02/11/26 | US$0.1120 | -83.08% | 47,445,500 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- KPTI Stock
Select your edition
All financial news and data tailored to specific country editions
